RecruitingPhase 2NCT07764497

Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis

A Phase II Study of Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Best Systemic Chemotherapy in Patients With Inoperable Hepatic Metastasis From Colorectal Cancer

Sponsor

Sunnybrook Health Sciences Centre

Enrollment

200 participants

Start Date

Jul 1, 2014

Study Type

INTERVENTIONAL

Conditions

Liver Metastasis Colon Cancer Liver Metastases From Colorectal Cancer Colorectal Adenocarcinoma Metastatic in the Liver Liver Metastases of Colorectal Cancer

Summary

The goal of this clinical trial is to assess how many patients with initially inoperable colorectal liver metastasis are able to have a liver surgery after treatment with hepatic artery infusion chemotherapy and standard of care systemic chemotherapy.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Floxuridine (FUDR) for people with colorectal adenocarcinoma metastatic in the liver, liver metastases from colorectal cancer, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.